[vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]For all groups with fewer than 3,000 insured and non-insured Administrative Services Only type (ASO) certificates[/vc_column_text][vc_column_text]In compliance with pooling process requirements for 2016, and, to the best of your knowledge, group eligibility and group sizes have been established according to the principle of joint entire responsibility as to risk, and that:[/vc_column_text][vc_empty_space height=”15px”][vc_row_inner][vc_column_inner][vc_column_text]
1. Exposure
- all admissible groups have been submitted;
- all groups presented for pooling have been established in compliance with applicable legislation and were still complying as of December 31, 2016;
- for
, proof of the exempt status is on file for all other employees; - when determining group size, all contracts financially inter-dependent for pricing under an agreement requested by the contract-holder/plan sponsor, even where separate contracts are issued, have been reported as one group;
- contracts linked because of the insurer’s or administrator’s policies or internal decisions are reported according to the risk sharing they represent;
- contracts linked as a result of a grouping set up by a duly authorized insurance representative (i.e. one holding a group insurance license) are reported according to the risk they represent when taken separately;
- all the certificate holders for the groups presented are compliant with the eligibility criteria as defined under but not limited to sections 15.1, 16, 42.1 and 42.2 of the Quebec Drug Insurance Act;
- the groups presented have not been grouped or split in order to take advantage of pooling;
- any “association” group presented exists for a reason other than to provide insurance for its members, who are natural persons linked by profession or habitual occupation.
[/vc_column_text][vc_empty_space height=”15px”][vc_column_text]
2. Claims
- for all groups, regardless of the size, the eligible and covered drugs are those of the private plan;
- for each certificate, the eligible and paid amount for which a payment was issued in 2016 has been reported;
- no claims adjudicated as a second payer have been included;
- any required additional information has been included for any contract numbers not included in the exposure above.
[/vc_column_text][vc_empty_space height=”15px”][vc_column_text]
3. Participants audited
For the participants audited, if the data submitted required corrections or if modifications to administrative practices were requested by the auditor, they have been processed.
[/vc_column_text][vc_empty_space height=”15px”][vc_column_text]
4. Compliance Undertaking
With regard to the declarations made above, I confirm that the enclosed information is taken from the company’s books. To the best of my knowledge, it is accurate as at December 31, 2016. I declare that I am authorized to sign on behalf of the participating company for which I am completing this compliance certificate. In witness whereof, I have signed:
[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_empty_space height=”15px”][/vc_column][/vc_row][vc_row][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_column_text css=”.vc_custom_1456764386094{border-top-width: 1px !important;border-right-width: 1px !important;border-bottom-width: 1px !important;border-left-width: 1px !important;padding-right: 5% !important;padding-bottom: 10px !important;padding-left: 5% !important;border-left-color: #005699 !important;border-left-style: solid !important;border-right-color: #005699 !important;border-right-style: solid !important;border-top-color: #005699 !important;border-top-style: solid !important;border-bottom-color: #005699 !important;border-bottom-style: solid !important;}”]
COMPLIANCE UNDERTAKING
Name of participating company:
Authorized signatory:
Title:
Company (if different) :
E-mail address:
Date (DD/MM/YY) : __/ __/__ Signature:
[/vc_column_text][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][vc_column_text]
UNDERLYING PRINCIPLES FOR POOLING DRUG CLAIMS IN QUEBEC
- The practices and activities used in managing plans in the marketplace must not permit any manipulation so as to avoid or to profit from risk pooling.
- The definition of a group used in establishing the pooling parameters is in accordance with industry standard practices and in compliance with the legislative requirements of the Quebec Insurance Act and the Public Prescription Drug Insurance Plan and applicable regulations.
[/vc_column_text][vc_empty_space height=”15px”][/vc_column][/vc_row][vc_row][vc_column][vc_text_separator title=”REMINDERS”][vc_column_text]The Corporation also reminds you that:
- the size of a group must be based on the number of certificates with drug insurance coverage (i.e. excluding those exempt from such coverage);
- the size of a group that terminated by the end of 2016 will be determined by the Pooling Manager, using the average number of certificates (Canadian) at the beginning and the end of the exposure period of the contract during the year.
- only drugs with a DIN or eligible NPN can be included in the total data submitted.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
For more information, please refer to the Corporation’s web site at www.pooling.ca
IMPORTANT:
Please download and complete this certificate of compliance, and mail it at
Mr. Philippe Dunn, Vias Ltée, 1850, avenue Panama, suite 610, Brossard (QC) J4W 3C6
[/vc_column_text][vc_empty_space][/vc_column][/vc_row]